Interactions of the alzheimer β amyloid fragment ((25-35)) with peripheral blood dendritic cells

Mechanisms of Ageing and Development

Volumn 94, Issue 1-3, 1997, Pages 223-232

  Schmitt, T L ^a   Steger, M M ^a   Pavelka, M ^b   Grubeck Loebenstein, B ^a  

^a Inst Biomed Aging Res Austrian A   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

A ((25 35)); Alzheimer amyloid; Dendritic cells; Immune system

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN [25-35]; CD11B ANTIGEN; CD18 ANTIGEN; CELL MEMBRANE MARKER; CYTOKINE; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VACUOLE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL DEATH; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PEPTIDE FRAGMENTS;

EID: 0030926062     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(97)01866-6     Document Type: Conference Paper

References (24)

1. D.J. Selkoe, Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci., 17 (1994) 489-517.
2. G.G. Glenner and C.W. Wong, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 120 (1984) 885-890.
3. A. Goate, M.C. Chartier-Harlin, M. Mullan et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349 (1991) 704-706.
4. M. Mullan, F. Crawford, K. Axelman et al., A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet., 1 (1992) 345-347.
5. R. Tanzi, J.F. Gusella, P.C. Watkins et al., Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 235 (1987) 880-884.
6. D. Games, D. Adams, R. Alessandrini et al., Alzheimer-neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature, 373 (1995) 523-527.
7. F. La Ferla, B. Tinkle, C. Bieberich, C. Handenschild and G. Jay, The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet., 9 (1995) 21-29.
8. C.J. Pike, D. Burdick, A.J. Walencewicz, C.G. Glabe and C.W. Cotman, Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci., 13 (1993) 1676-1687.
9. K. Trieb, G.Ransmayr, R. Sgonc, H. Lassmann and B. Grubeck-Loebenstein, APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol. Aging, 17 (1996) 541-547.
10. R.M. Steinman, The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9 (1991) 271-296.
11. F. Sanchez-Madrid, A. Krensky, C. Ware et al., Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci USA, 79 (1982) 7489-7493.
12. F. Sallusto and A. Lanzavecchia, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor-α. J. Exp. Med., 179 (1994) 1109-1118.
13. M.M. Steger, C. Maczek and B. Grubeck-Loebenstein, Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin. Exp. Immunol., 105 (1996) 544-550.
14. H. Lechner, M. Amort, M.M. Steger, C. Maczek and B. Grubeck-Loebenstein, Regulation of CD95(APO-1) expression and the induction of apoptosis in human T cells: changes in old age. Int. Arch. Allergy Immunol., 110 (1996) 238-243.
15. L.L. Iversen, J. Mortishire, S.J. Pollack and M.S. Shearman, The toxicity in vitro of β-amyloid protein. Biochem. J., 311 (1995) 1-16.
16. L.M. Shaffer, M.D. Dority, R. Grupta-Bausal, R.C. Frederickson, S.G. Jounkin and K.R. Brunden, Amyloid beta protein removal by neuroglial cells in culture. Neurobiol. Aging, 16 (1995) 737-745.
17. J. Frackowiak, H.M. Wisniewski, J. Wegiel, G.S. Merz, K. Iqbal and K.C. Wang, Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropath., 84 (1992) 225-233.
18. G.W. Roberts, S.M. Gentleman, A. Lynch, L. Murray, M. Landon and D.I. Graham, Beta-amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psych., 57 (1994) 419-425.
19. W.A.Van Gool, D.B. Schenk and P.A. Bolhuis, Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett., 172 (1994) 122-124.
20. L. Meda, M.A. Cassatella, G.I. Szendrei et al., Activation of microglial cells by β-amyloid protein and interferon-γ. Nature, 374 (1995) 647-650.
21. M.A. Kowalska and K. Badellino, Beta-amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem. Biophys. Res. Commun., 205 (1994) 1829-1835.
22. B.D. Gitter, L.M. Cox, R.E. Rydel and P.C. May, Amyloid β peptide potentiates cytokine secretion by interleukin-1β activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA, 92 (1995) 10738-10741.
23. P.L. McGeer and E.G. McGeer, Chronic inflammatory mechanism of the brain: implications for the treatment of Alzheimer disease. Dementia, 9 (1995) 111-123.
24. R. Veerhuis, S. Zhan and P. Eikelenboom, Role of inflammation and complement activation in Alzheimer's disease. In: P. Zatta and M. Nicolini (eds.), Non-Neuronal Cells in Alzheimer's Disease, World Scientific, Singapore, 1995, pp. 171-193.